GnuBIO Inc. said it is moving to larger space in Cambridge as it expands operations.
With 11,000 square feet of space, the new office at One Kendall Square is more than twice as large as the current office at Sidney Street, which is also in Cambridge.
GnuBIO is a privately-held company developing next-generation desktop DNA sequencing technology that will compartmentalize the entire DNA sequencing process, combining all of the steps required for sequencing into a single system.
The company has 20 full-time employees and plans to double in size, a company spokeswoman said.
The move to Kendall Square will help GnuBIO’s transition “into the commercial phase of the company,” president and chief executive John Boyce said in a statement.
Founded in 2009, the company has raised $8 million in private funding to date, the spokeswoman said.